-
Bharti Airtel
1,956.00 2,174.70(%) -
Bluestone Jewel
872.60 872.60(%) -
Anthem Bioscienc
735.10 579.45(%) -
IndusInd Bank
1,077.80 1,077.80(%) -
M & M Fin. Serv.
384.55 412.30(%) -
Data Pattern
4,800.00 4,955.00(%) -
TVS Motor Co.
3,965.00 3,970.00(%) -
Cummins India
5,635.00 6,142.80(%) -
Bajaj Auto
11,025.00 11,025.00(%) -
SBI Funds Mgt.
582.55 582.55(%) -
Bandhan Bank
169.65 134.30(%) -
HDFC Bank
750.25 726.75(%) -
Kalyan Jewellers
601.25 617.30(%) -
Eternal
275.70 212.55(%) -
Reliance Industries
1,284.00 1,253.65(%) -
Bajaj Finance
1,056.30 788.40(%) -
Dixon Technolog.
13,650.00 9,605.05(%) -
Himadri Special
760.20 420.00(%) -
Titan Company
4,730.10 4,730.10(%) -
Nestle India
1,509.75 1,509.75(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Colinz Laboratories Ltd Pharmaceuticals - Indian - Formulations
- Indian Private
- BSE Code : 5989.0
- ISIN : INE923C01011
-
Today’s Low
77.90 -
Today’s High
84.45
-
Open
82.00 -
Perv Close
82.00 -
52W Low
36.11 -
52W High
87.91
Key Indicators
-
P/E(TTM)
19.64
-
Mar.Cap (₹Cr.)
10.09
-
Div & Yield %
0.00
-
Book Value(₹)
69.70
-
Debt-Equity Ratio
-2.28
-
AGM Date
22-Jul-2026
-
EPS
4.08
-
P/E Ratio
19.64
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
10.09
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
1.26
-
BV (₹)
69.70
-
Sales( ₹ in Cr.)
6.14
-
NP (in Cr.)
0.51
-
NP Var(%)
3.0
-
Div%
0.0
-
CPS (₹)
5.30
-
EPS (₹)
4.10
-
Traded Value (₹ in Lakhs)
10.09
-
52 Week High
87.91
-
52 Week Low
36.11
-
Price BSE
80.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
10.09
-
P/C Ratio
15.00
-
P/E Ratio
19.60
-
Price Vs.BV
4.10
-
20-Jul-2026( 09:50)
Corporate News - Colin... - Colinz Laboratories will hold...
-
30-Apr-2026( 07:34)
Results - Announcements - Colin... - Net profit of Colinz Laborator...
-
21-Apr-2026( 05:43)
Corporate News - Colin... - Colinz Laboratories will hold...
-
27-Jan-2026( 07:34)
Results - Announcements - Colin... - Net profit of Colinz Laborator...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 6.53 | 7.03 | 7.15 | 6.97 | 6.16 | 7.60 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
| Net Sales | 6.53 | 7.03 | 7.15 | 6.97 | 6.16 | 7.53 |
| Other Income | 0.30 | 0.28 | 0.17 | 0.17 | 0.19 | 0.13 |
| Stock Adjustments | -0.08 | -0.08 | 0.03 | -0.33 | -0.47 | -0.12 |
| Total Income | 6.75 | 7.23 | 7.35 | 6.81 | 5.88 | 7.54 |
| EXPENDITURE : | ||||||
| Raw Materials | 2.01 | 2.23 | 2.33 | 1.97 | 1.72 | 2.62 |
| Power and Fuel Cost | 0.12 | 0.11 | 0.11 | 0.08 | 0.08 | 0.09 |
| Employee Cost | 2.67 | 2.79 | 2.90 | 2.77 | 2.39 | 3.25 |
| Other Manufacturing Expenses | 0.10 | 0.23 | 0.14 | 0.14 | 0.13 | 0.06 |
| Selling and Administration Expenses | 1.05 | 1.04 | 1.08 | 1.03 | 0.96 | 1.08 |
| Miscellaneous Expenses | 0.01 | 0.00 | 0.03 | 0.06 | 0.09 | 0.01 |
| Employee Benefit Expenses | 2.67 | 2.79 | 2.90 | 2.77 | 2.39 | 3.25 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 5.95 | 6.40 | 6.58 | 6.06 | 5.36 | 7.11 |
| Operating Profit | 0.79 | 0.82 | 0.78 | 0.76 | 0.53 | 0.44 |
| Interest | 0.04 | 0.04 | 0.05 | 0.08 | 0.09 | 0.07 |
| Gross Profit | 0.75 | 0.78 | 0.73 | 0.68 | 0.44 | 0.37 |
| Depreciation | 0.13 | 0.13 | 0.13 | 0.20 | 0.19 | 0.19 |
| Profit Before Tax | 0.62 | 0.65 | 0.60 | 0.48 | 0.25 | 0.18 |
| Current Tax | 0.18 | 0.18 | 0.16 | 0.15 | 0.08 | 0.07 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.05 | -0.01 | -0.02 | -0.01 | -0.04 | -0.02 |
| Reported Net Profit | 0.50 | 0.49 | 0.46 | 0.34 | 0.21 | 0.13 |
| Extraordinary Items | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 0.50 | 0.49 | 0.48 | 0.34 | 0.21 | 0.13 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | 2.96 | 2.47 | 2.01 | 1.67 | 1.47 | 1.34 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 3.45 | 2.96 | 2.47 | 2.01 | 1.67 | 1.47 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 1.97 | 1.93 | 1.82 | 0.96 | 0.59 | 0.37 |
| Earnings Per Share(Adj)-Unit Curr | 1.97 | 1.93 | 1.82 | 0.96 | 0.59 | 0.37 |
| Book Value | 37.61 | 35.52 | 32.31 | 21.69 | 20.57 | 19.29 |
| Book Value(Adj)-Unit Curr | 37.61 | 35.52 | 32.31 | 21.69 | 20.57 | 19.29 |
